CLEC16A and myeloid sarcoma: An association between a genomic region containing Mhc2ta and other MS candidate genes Clec16a, Dexi, and Socs1 (11) and an increased risk for MS, RA, and myocardial infarction indicates correlation between quantitative aspect of MHC class II and susceptibility to MS (12).